CAS: 1443437-74-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]- REF: IN-DA001JDDCAS: 1443437-74-8 | 98% | 79.00 €~635.00 € | Tue 10 Dec 24 | |
CCG-203971 REF: TM-T4306CAS: 1443437-74-8 | 98.82% - 99.35% | To inquire | Fri 13 Dec 24 | |
CCG 203971 REF: 3D-FC76600CAS: 1443437-74-8 | Min. 95% | To inquire | Fri 17 Jan 25 |
3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-
CAS:1443437-74-8
Formula:
C23H21ClN2O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
408.8774
Ref: IN-DA001JDD
1g | 635.00 € | ||
5mg | 79.00 € | ||
10mg | 115.00 € | ||
25mg | 152.00 € | ||
100mg | 164.00 € | ||
250mg | 261.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
CCG-203971
CAS:1443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: …
Formula:
C23H21ClN2O3
Purity:
98.82% - 99.35%
Color and Shape:
Solid
Molecular weight:
408.88
Ref: TM-T4306
10mg | 53.00 € | ||
25mg | 94.00 € | ||
50mg | 144.00 € | ||
100mg | 224.00 € | ||
500mg | 553.00 € | ||
1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
CCG 203971
CAS:1443437-74-8
Inhibits MRTF-SRF transcriptional pathway
Formula:
C23H21ClN2O3
Purity:
Min. 95%
Molecular weight:
408.88 g/mol
Ref: 3D-FC76600
10mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025